These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 9238953)
1. Dexfenfluramine. Spollett G Lippincotts Prim Care Pract; 1997; 1(3):320-3. PubMed ID: 9238953 [No Abstract] [Full Text] [Related]
2. New treatment for obesity: dexfenfluramine (Redux). Bihm B Medsurg Nurs; 1996 Oct; 5(5):360-2, 373. PubMed ID: 8981871 [No Abstract] [Full Text] [Related]
3. Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned? Voelkel NF; Clarke WR; Higenbottam T Am J Respir Crit Care Med; 1997 Mar; 155(3):786-8. PubMed ID: 9117009 [No Abstract] [Full Text] [Related]
4. A close look at fenfluramine and dexfenfluramine. Vivero LE; Anderson PO; Clark RF J Emerg Med; 1998; 16(2):197-205. PubMed ID: 9543401 [TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for obesity -- do the benefits outweigh the risks? Manson JE; Faich GA N Engl J Med; 1996 Aug; 335(9):659-60. PubMed ID: 8687523 [No Abstract] [Full Text] [Related]
6. [The role of anorexigenics in the treatment of obesity]. Laroche C; Boissonnas A Therapie; 1979; 34(2):181-95. PubMed ID: 386556 [No Abstract] [Full Text] [Related]
7. Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity. Anchors M Arch Intern Med; 1997 Jun; 157(11):1270. PubMed ID: 9183245 [No Abstract] [Full Text] [Related]
16. Weighing benefits and risks of drug to treat obesity. Sukkari SR CMAJ; 1997 Mar; 156(6):768-9. PubMed ID: 9084379 [No Abstract] [Full Text] [Related]
17. Somatometric and hormonal effects of dexfenfluramine. Sonka J; Marek J; Svacina S; Sucharda P; Stĕpán J Sb Lek; 1995; 96(4):299-301. PubMed ID: 8711372 [TBL] [Abstract][Full Text] [Related]